Levetiracetam

Product manufactured by Remedyrepack Inc.

Application Nr Approved Date Route Status External Links
ANDA090515 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Levetiracetam Tablet Is Indicated As Adjunctive Therapy In The Treatment Of Partial Onset Seizures In Adults And Children 4 Years Of Age And Older With Epilepsy. Levetiracetam Tablet Is Indicated As Adjunctive Therapy In The Treatment Of Myoclonic Seizures In Adults And Adolescents 12 Years Of Age And Older With Juvenile Myoclonic Epilepsy. Levetiracetam Tablet Is Indicated As Adjunctive Therapy In The Treatment Of Primary Generalized Tonic-Clonic Seizures In Adults And Children 6 Years Of Age And Older With Idiopathic Generalized Epilepsy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levetiracetam LEVETIRACETAM ZINC1547851

Comments